| Literature DB >> 32326459 |
Jon Alberdi-Cedeño1, María L Ibargoitia1, María D Guillén1.
Abstract
The effect of enriching virgin flaxseed oil with dodecyl gallate, hydroxytyrosol acetate or gamma-tocopherol on its in vitro digestion is studied by means of proton nuclear magnetic resonance and solid phase microextraction followed by gas chromatography/mass spectrometry. The extent and pattern of the lipolysis reached in each sample is analyzed, as is the bioaccessibility of the main oil components. None of the phenolic compounds provokes inhibition of the lipase activity and all of them reduce the lipid oxidation degree caused by the in vitro digestion and the bioaccessibility of oxidation compounds. The antioxidant efficiency of the three tested phenols is in line with the number of phenolic groups in its molecule, and is dose-dependent. The concentration of some minor oil components such as terpenes, sesquiterpenes, cycloartenol and 24-methylenecycloartenol is not modified by in vitro digestion. Contrarily, gamma-tocopherol shows very low in vitro bioaccessibility, probably due to its antioxidant behavior, although this increases with enrichment of the phenolic compounds. Oxidation is produced during in vitro digestion even in the presence of a high concentration of gamma-tocopherol, which remains bioaccessible after digestion in the enriched samples of this compound.Entities:
Keywords: antioxidant efficiency; bioaccessibility; dodecyl gallate; gamma-tocopherol; hydroxytyrosol acetate; in vitro digestion; minor compounds; oxidation; virgin flaxseed oil
Year: 2020 PMID: 32326459 PMCID: PMC7222186 DOI: 10.3390/antiox9040312
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Region between 0.0 and 4.9 ppm of flaxseed virgin oil, F, 1H NMR spectrum, and enlargement of the region between 3.5 ppm and 5.10 ppm of the 1H NMR of the lipid extracted from the digestate, DF. The signal letters agree with those of Tables S2 and S3 of Supplementary Material.
Figure 2(A) Chemical structures of the phenolic compounds involved in this study (gamma-tocopherol γT, hydroxytyrosol acetate hydroxytyrosol acetate (HTA) and dodecyl gallate dodecyl gallate (DG), together with some chemical shifts (ppm) of the 1H NMR signals of some of their hydrogen atoms. (B) Enlargement of some regions of the 1H NMR spectra of nonenriched F and some enriched oil samples (FγT2, FHTA2 and FDG2), in which the signals of the aforementioned phenolic compounds appear. The signal letters agree with those of Table S5.
Lipolysis extent. Molar percentages of triglycerides (TG), diglycerides (1,2-DG and 1,3-DG), monoglycerides (1-MG and 2-MG), and glycerol (Gol) in relation to the total glyceride structures in virgin flaxseed oil samples (F), in the digestate of this oil (DF), and in the samples enriched in dodecyl gallate, hydroxytyrosol acetate, and gamma-tocopherol (DFDG1, DFDG2, DFHTA1, DFHTA2 DFγT1, DFγT2, DFγT3 and DFγT4). Bioaccessibility of oil main components after in vitro digestion (BOMC), defined by the ratio (mol [FA] + [MG])D /mol ([FA] + [AG])D.
| Samples | Lipolysis Extent (Molar %) | Bioaccessibility | |||||
|---|---|---|---|---|---|---|---|
| TG (%) | 1,2-DG (%) | 2-MG (%) | 1,3-DG (%) | 1-MG (%) | Gol (%) | ||
| Oil | |||||||
| F | 99.4 ± 0.0a | 1.2 ± 0.0a | - | - | - | - | - |
| DF | 33.1 ± 2.7b | 18.1 ± 2.1b | 21.7 ± 0.5a | 4.8 ± 1.0a | 2.2 ± 0.8a | 20.2 ± 4.3a | 0.52 ± 0.05a |
| Oil-dodecyl gallate | |||||||
| DFDG1 | 33.6 ± 0.3b | 16.8 ± 0.2b | 20.3 ± 0.0a | 6.0 ± 0.3a | 1.6 ± 0.1a | 21.9 ± 0.0a | 0.51 ± 0.00a |
| DFDG2 | 32.7 ± 1.9b | 17.3 ± 1.2b | 20.6 ± 2.1a | 4.7 ± 0.2a | 2.6 ± 0.1a | 22.1 ± 1.8a | 0.53 ± 0.01a |
| Oil-hydroxytyrosol acetate | |||||||
| DFHTA1 | 32.4 ± 0.5b | 17.1 ± 0.4b | 20.5 ± 1.5a | 5.3 ± 0.2a | 2.1 ± 0.1a | 22.6 ± 2.0a | 0.53 ± 0.01a |
| DFHTA2 | 31.2 ± 0.5b | 16.6 ± 0.4b | 22.3 ± 0.5a | 4.3 ± 0.4a | 2.0 ± 0.2a | 23.7 ± 2.0a | 0.55 ± 0.01a |
| Oil-gamma-tocopherol | |||||||
| DFγT1 | 32.3 ± 0.9b | 17.9 ± 2.5b | 22.3 ± 0.7a | 3.9 ± 0.9a | 1.5 ± 0.1a | 22.2 ± 3.3a | 0.53 ± 0.01a |
| DFγT2 | 32.4 ± 2.0b | 16.9 ± 0.1b | 20.3 ± 0.5a | 5.5 ± 2.9a | 1.4 ± 0.1a | 23.4 ± 0.5a | 0.53 ± 0.00a |
| DFγT3 | 30.1 ± 0.7b | 17.3 ± 0.0b | 20.2 ± 0.6a | 7.4 ± 0.4a | 2.2 ± 0.1a | 22.7 ± 0.9a | 0.53 ± 0.00a |
| DFγT4 | 32.4 ± 0.0b | 17.6 ± 0.9b | 20.6 ± 0.6a | 4.4 ± 0.5a | 2.1 ± 0.0a | 22.9 ± 0.9a | 0.53 ± 0.01a |
Different letters within each column indicate a statistically significant difference among the samples (p < 0.05). A dash indicates “not detected”.
Concentration of linolenic structures given in molar percentage in relation to the total moles of AG + FA present in the virgin flaxseed oil F, in the digestate of this oil DF, and in those of the samples enriched in hydroxytyrosol acetate, dodecyl gallate, and gamma-tocopherol (DFDG1, DFDG2, DFHTA1, DFHTA2, DFγT1, DFγT2, DFγT3, and DFγT4), together with the enrichment level of phenolic compounds in the samples before digestion. The concentrations of oxidation compounds such as hydroperoxides and n-alkanals in the same samples determined from 1H NMR spectral data.
| Oil, Digestates, and Enrichment Level in Phenolic Compounds of the Oil Samples before Digestion, Given in mmol/mol [AG + FA] | Linolenic Structures | Oxidation Compounds | |
|---|---|---|---|
| HPO-c( | n-alkanals | ||
| Oil | |||
| F | 55.7 ± 0.0a | - | - |
| DF | 47.9 ± 0.8d | 0.39 ± 0.04a | 0.09 ± 0.00a |
| Oil-dodecyl gallate | |||
| DFDG1 (0.14) | 50.9 ± 1.1abc | 0.33 ± 0.04ab | 0.08 ± 0.01a |
| DFDG2 (1.35) | 53.1 ± 1.8ab | 0.28 ± 0.02b | 0.07 ± 0.01a |
| Oil-hydroxytyrosol acetate | |||
| DFHTA1 (0.24) | 50.9 ± 1.1abc | 0.30 ± 0.02b | 0.08 ± 0.00a |
| DFHTA2 (2.65) | 53.7 ± 0.3ab | n.d. | 0.07 ± 0.00a |
| Oil-gamma-tocopherol | |||
| DFγT1 (0.13) | 48.5 ± 3.1d | 0.40 ± 0.02a | 0.09 ± 0.01a |
| DFγT2 (1.30) | 51.8 ± 1.0abc | 0.33 ± 0.02ab | 0.07 ± 0.01a |
| DFγT3 (14.21) | 53.8 ± 0.1ab | - | 0.07 ± 0.00a |
| DFγT4 (32.79) | 55.2 ± 0.2a | - | 0.04 ± 0.00b |
Different letters within each column indicate a statistically significant difference among the samples (p < 0.05), -: not detected; n.d.: not determined due to interfering signals; HPO-c(Z,E)-dEs: hydroperoxy-conjugated (Z,E)-dienes.
Abundances of some volatile oxidation markers extracted by SPME from the headspace of the mixture of digestive juices and virgin flaxseed oil FDJ, from the digestate of this oil DF, and from the digestates of the samples enriched in dodecyl gallate, hydroxytyrosol acetate, and gamma-tocopherol (DF, DFDG1, DFDG2, DFHTA1, DFHTA2, DFγT1, DFγT2, DFγT3, and DFγT4), separated, identified, and semiquantified by GC/MS, together with the enrichment level of each phenol in each oil sample before digestion given in mmol/mol (AG + FA)O. Data are expressed as area counts of the mass spectra base peak (Bp) of each compound multiplied by 10−6, obtained as the average of two determinations, together with their standard deviations.
| Compound (Molecular Weight) | Bp | FDJ | DF | DFDG1
| DFDG2
| DFHTA1
| DFHTA2
| DFγT1
| DFγT2
| DFγT3
| DFγT4
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aldehydes | |||||||||||
|
| |||||||||||
| Pentanal (86) * | 44 | 10.60 ± 3.78 | 65.99 ± 5.57 | 38.23 ± 4.68 | 35.09 ± 1.29 | 54.45 ± 0.84 | 35.19 ± 0.68 | 77.53 ± 7.47 | 55.66 ± 3.44 | 39.70 ± 4.33 | 31.03 ± 2.10 |
| Hexanal (100) * | 44 | 7.85 ± 2.16 | 63.22 ± 9.92 | 56.89 ± 7.03 | 52.86 ± 1.25 | 66.69 ± 6.45 | 51.03 ± 5.29 | 63.71 ± 2.84 | 55.52 ± 3.62 | 45.84 ± 2.07 | 39.02 ± 0.55 |
| Heptanal (114) * | 70 | 0.49 ± 0.05 | 4.10 ± 0.03 | 3.30 ± 0.98 | 2.16 ± 0.23 | 3.61 ± 0.35 | 3.70 ± 0.05 | 4.67 ± 0.07 | 4.17 ± 0.18 | 3.14 ± 0.01 | 2.80 ± 0.05 |
| Octanal (128) * | 41 | - | 7.71 ± 0.51 | - | - | - | - | 8.36 ± 0.20 | - | - | - |
| Nonanal (142) * | 57 | 2.97 ± 0.80 | 12.05 ± 1.17 | 15.73 ± 4.14 | 10.02 ± 0.57 | 11.21 ± 3.46 | 10.75 ± 0.32 | 14.98 ± 4.65 | 11.79 ± 0.55 | 9.55 ± 0.67 | 8.70 ± 0.12 |
|
| 21.91 ± 6.78 | 153.07 ± 17.52 | 114.14 ± 16.83 | 100.14 ± 3.34 | 135.96 ± 11.10 | 100.67 ± 6.34 | 169.25 ± 15.23 | 127.14 ± 7.79 | 98.23 ± 7.09 | 81.55 ± 2.82 | |
|
| |||||||||||
| ( | 55 | 2.23 ± 0.29 | 10.67 ± 0.34 | 5.24 ± 0.44 | 5.64 ± 0.13 | 6.70 ± 1.15 | 5.12 ± 1.15 | 8.25 ± 0.82 | 5.41 ± 0.55 | 5.96 ± 1.04 | 5.46 ± 0.29 |
| ( | 41 | 0.39 ± 0.07 | 1.38 ± 0.03 | 0.77 ± 0.07 | 0.43 ± 0.15 | 0.79 ± 0.03 | 0.60 ± 0.01 | 1.03 ± 0.03 | 1.14 ± 0.16 | 0.95 ± 0.03 | 0.53 ± 0.03 |
| ( | 41 | 1.53 ± 0.06 | 6.09 ± 1.40 | 4.27 ± 0.49 | 4.55 ± 0.44 | 4.78 ± 0.06 | 3.74 ± 0.42 | 6.18 ± 1.82 | 4.50 ± 0.38 | 3.61 ± 0.44 | 2.87 ± 0.14 |
| ( | 55 | - | 0.32 ± 0.01 | - | - | - | - | 2.9 ± 0.1 | - | - | - |
|
| 4.15 ± 0.41 | 18.46 ± 1.77 | 10.21 ± 1.00 | 10.63 ± 0.73 | 12.26 ± 1.24 | 10.02 ± 1.82 | 15.76 ± 2.69 | 11.05 ± 1.09 | 10.52 ± 1.58 | 8.86 ± 0.46 | |
|
| |||||||||||
| ( | 81 | - | 2.86 ± 0.21 | 1.19 ± 0.11 | 1.14 ± 1.8 | 1.60 ± 0.16 | 1.18 ± 0.34 | 1.64 ± 0.04 | 1.87 ± 0.04 | 1.25 ± 0.14 | 1.06 ± 0.00 |
| ( | 81 | 3.31 ± 0.93 | 19.66 ± 0.62 | 9.35 ± 0.15 | 7.97 ± 0.37 | 14.02 ± 0.50 | 8.07 ± 1.48 | 14.05 ± 0.46 | 12.48 ± 0.08 | 11.54 ± 1.35 | 8.35 ± 0.78 |
| ( | 81 | 2.24 ± 0.39 | 21.30 ± 0.66 | 17.38 ± 0.66 | 10.49 ± 0.19 | 19.02 ± 0.08 | 11.62 ± 0.66 | 19.79 ± 3.60 | 13.34 ± 0.29 | 12.77 ± 1.19 | 11.21 ± 0.44 |
|
| 5.55 ± 1.32 | 43.81 ± 1.48 | 27.92 ± 0.92 | 19.60 ± 0.74 | 34.64 ± 0.73 | 20.87 ± 2.49 | 35.48 ± 4.12 | 27.69 ± 0.41 | 25.57 ± 2.68 | 20.63 ± 1.23 | |
| Aromatic aldehydes | |||||||||||
| Benzaldehyde (106) * | 106 | 3.85 ± 1.71 | 8.15 ± 1.06 | 4.50 ± 0.30 | 5.11 ± 0.31 | 6.79 ± 0.59 | 6.71 ± 0.89 | 7.08 ± 1.01 | 6.99 ± 1.03 | 6.32 ± 0.51 | 5.25 ± 0.13 |
| Furan derivatives | |||||||||||
| Furan, 2-ethyl (96) * | 81 | 1.88 ± 0.03 | 6.29 ± 2.64 | 4.51 ± 0.64 | 3.59 ± 0.22 | 4.64 ± 0.38 | 3.12 ± 0.43 | 6.91 ± 2.0 | 3.30 ± 0.72 | 3.34 ± 0.89 | 2.81 ± 0.77 |
| Furan, 2-butyl (124) | 81 | 0.29 ± 0.04 | 0.46 ± 0.08 | - | - | - | - | 0.70 ± 0.28 | 0.70 ± 0.01 | - | - |
| Furan, 2-pentyl (138) * | 81 | 4.20 ± 1.11 | 11.69 ± 0.71 | 9.83 ± 0.43 | 8.50 ± 0.42 | 11.20 ± 0.37 | 10.13 ± 0.13 | 11.12 ± 0.50 | 11.53 ± 0.47 | 11.28 ± 0.09 | 9.25 ± 0.18 |
|
| 6.37 ± 1.18 | 18.43 ± 3.42 | 13.94 ± 1.04 | 12.09 ± 0.64 | 15.84 ± 0.75 | 13.25 ± 0.56 | 18.72 ± 0.98 | 15.52 ± 1.20 | 14.62 ± 0.98 | 12.06 ± 0.95 | |
| Ketones | |||||||||||
| 2,3-Pentanedione (100) * | 43 | 1.64 ± 0.12 | 26.39 ± 8.58 | 24.25 ± 2.21 | 9.78 ± 0.30 | 19.24 ± 0.77 | 16.58 ± 0.43 | 25.22 ± 5.44 | 14.00 ± 1.73 | 4.54 ± 0.05 | 3.32 ± 0.41 |
| 2-Hexanone (100) | 43 | 0.58 ± 0.02 | 2.46 ± 0.10 | 1.20 ± 0.28 | 1.55 ± 0.43 | 1.83 ± 0.04 | 1.02 ± 0.03 | 1.94 ± 0.15 | 1.38 ± 0.06 | 1.59 ± 0.00 | 1.18 ± 0.21 |
| 2-Heptanone (114) * | 43 | 5.63 ± 0.12 | 9.27 ± 0.56 | 9.58 ± 1.01 | 6.75 ± 0.14 | 8.68 ± 1.65 | 7.40 ± 0.12 | 9.79 ± 1.37 | 8.24 ± 0.54 | 7.31 ± 0.83 | 6.79 ± 0.42 |
| 2,3-Octanedione (142) | 43 | 1.49 ± 0.29 | 6.92 ± 1.25 | 6.09 ± 0.13 | 4.38 ± 0.00 | 6.68 ± 0.49 | 5.50 ± 0.31 | 6.50 ± 0.46 | 6.31 ± 0.34 | 4.55 ± 0.14 | 2.21 ± 0.01 |
| 2-Octanone (128) * | 43 | 2.14 ± 0.01 | 3.84 ± 0.57 | 3.71 ± 0.70 | 3.26 ± 0.07 | 3.76 ± 0.08 | 2.56 ± 0.34 | 4.24 ± 0.47 | 3.99 ± 0.24 | 3.67 ± 0.14 | 2.47 ± 0.05 |
| 3-Octen-2-one (126) | 55 | 1.15 ± 0.12 | 1.91 ± 0.37 | 1.52 ± 0.04 | 1.21 ± 0.21 | 2.00 ± 0.11 | 0.96 ± 0.05 | 1.85 ± 0.34 | 1.95 ± 0.29 | 1.05 ± 0.48 | 0.96 ± 0.32 |
| 3 | 95 | 0.78 ± 0.08 | 9.40 ± 0.18 | 5.40 ± 0.11 | 2.17 ± 0.01 | 7.98 ± 0.05 | 2.70 ± 0.19 | 6.13 ± 0.16 | 3.23 ± 0.11 | 2.15 ± 0.07 | 1.97 ± 0.13 |
|
| 13.41 ± 0.69 | 60.18 ± 11.62 | 49.94 ± 4.49 | 29.09 ± 1.16 | 50.16 ± 3.20 | 36.72 ± 1.41 | 55.67 ± 8.39 | 39.11 ± 3.32 | 24.85 ± 1.72 | 18.90 ± 1.56 | |
| Alcohols | |||||||||||
| 1-Hexanol (102) * | 56 | 10.53 ± 1.15 | 12.55 ± 1.51 | 13.15 ± 0.16 | 9.02 ± 0.45 | 9.38 ± 0.52 | 8.61 ± 0.02 | 12.09 ± 0.09 | 9.73 ± 0.85 | 8.02 ± 0.73 | 5.26 ± 0.19 |
| 1-Octen-3-ol (128) * | 57 | - | 8.62 ± 0.97 | 11.09 ± 0.19 | 6.72 ± 0.56 | 10.74 ± 0.87 | 6.10 ± 0.53 | 9.63 ± 0.28 | 6.24 ± 0.57 | 5.51 ± 0.35 | 2.53 ± 0.11 |
|
| 10.53 ± 1.15 | 21.17 ± 2.48 | 24.24 ± 0.35 | 15.74 ± 1.01 | 20.12 ± 1.38 | 14.72 ± 0.55 | 21.72 ± 0.37 | 15.97 ± 1.43 | 13.53 ± 1.09 | 7.79 ± 0.29 |
* Asterisked compounds were acquired commercially and used as standards for identification purposes; -: not detected.
In vitro bioaccessibility of gamma-tocopherol in the different samples, defined by BγT = mmol (γT)D/mol (AF + GA)D and by B’γT = mmol(γT)D/mmol (γT)O Values are the average of two determinations together with their standard deviations.
| Samples | BγT | B’γT |
|---|---|---|
| Oil | ||
| DF | 0.04 ± 0.01 | 0.12 ± 0.00 |
| Oil-dodecyl gallate | ||
| DFDG1 | 0.14 ± 0.00 | 0.42 ± 0.01 |
| DFDG2 | 0.16 ± 0.01 | 0.48 ± 0.03 |
| Oil-hydroxytyrosol acetate | ||
| DFHTA1 | 0.13 ± 0.00 | 0.39 ± 0.02 |
| DFHTA2 | 0.16 ± 0.01 | 0.48 ± 0.01 |
| Oil-gamma-tocopherol | ||
| DFγT1 | 0.09 ± 0.01 | 0.19 ± 0.05 |
| DFγT2 | 0.95 ± 0.03 | 0.58 ± 0.02 |
| DFγT3 | 11.41 ± 0.29 | 0.78 ± 0.02 |
| DFγT4 | 28.73 ± 0.27 | 0.86 ± 0.01 |
Terpenes and sesquiterpenes of virgin flaxseed oil, detected by SPME-GC/MS in the headspaces of the mixture of digestive juices submitted to digestive conditions and virgin flaxseed oil FDJ, of the digestate of this oil DF and of the digestates of the samples enriched with different levels of dodecyl gallate, hydroxytyrosol acetate, and gamma-tocopherol (DFDG, DFHTA, DFγT). Data are average abundances expressed as area counts of the mass spectra base peak Bp of each compound multiplied by 10−6, together with their standard deviations. For samples enriched with phenolic compounds, data given are average values of the abundances of the headspace of digestates coming from samples having different enrichment levels of phenolic compounds.
|
| Bp | FDJ | DF | DFDGaverage | DFHTAaverage | DFγTaverage |
|---|---|---|---|---|---|---|
| alpha-thujene | 93 | 24.33 ± 2.42a | 41.87 ± 5.39b | 38.49 ± 6.62b | 38.30 ± 1.85b | 44.45 ± 3.34b |
| alpha-pinene * | 93 | 18.81 ± 2.07a | 35.15 ± 8.52b | 31.32 ± 4.24b | 30.79 ± 1.48b | 33.11 ± 4.63b |
| Sabinene | 93 | 2.10 ± 0.13a | 3.27 ± 0.01b | 2.44 ± 0.42a | 2.49 ± 0.08a | 2.80 ± 0.41ab |
| beta-pinene * | 93 | 4.70 ± 0.25a | 10.90 ± 0.74b | 8.88 ± 1.34bc | 8.15 ± 0.31c | 8.86 ± 1.09bc |
| l-phellandrene * | 93 | 0.28 ± 0.07a | 0.45 ± 0.08b | 0.50 ± 0.07b | 0.39 ± 0.06ab | 0.49 ± 0.06b |
| delta-3-carene | 93 | 1.04 ± 0.15a | 2.79 ± 0.07b | 2.40 ± 0.11bc | 1.92 ± 0.09c | 2.30 ± 0.28c |
| alpha-terpinene * | 93 | 0.56 ± 0.28a | 1.70 ± 0.02b | 1.22 ± 0.18cd | 1.14 ± 0.15d | 1.56 ± 0.15bc |
| Cymene * | 119 | 189.10 ± 0.54a | 240.24 ± 24.37b | 243.91 ± 15.58b | 268.78 ± 12.34b | 248.03 ± 18.38b |
| Limonene * | 68 | 18.32 ± 1.29a | 35.81 ± 0.95b | 37.24 ± 1.54b | 32.21 ± 1.88b | 33.96 ± 3.74b |
| gamma-terpinene * | 93 | 2.45 ± 0.31a | 4.95 ± 0.58b | 4.10 ± 0.78b | 4.27 ± 0.12b | 4.65 ± 0.49b |
| alpha-terpinolene * | 93 | 0.25 ± 0.01a | 0.35 ± 0.07ab | 0.45 ± 0.06b | 0.40 ± 0.06ab | 0.43 ± 0.08b |
| 4-Terpineol * | 71 | 0.22 ± 0.03a | 2.49 ± 0.04b | 2.15 ± 0.52bc | 1.77 ± 0.05c | 2.55 ± 0.19b |
| alpha-terpineol * | 59 | 0.28 ± 0.03a | 1.61 ± 0.13b | 1.27 ± 0.22b | 1.21 ± 0.08b | 1.59 ± 0.18b |
| Carvone * | 82 | 1.63 ± 0.30a | 4.36 ± 0.46bc | 4.54 ± 0.40c | 3.38 ± 0.25b | 4.75 ± 0.62c |
| alpha-copaene | 119 | 0.21 ± 0.03a | 0.54 ± 0.02bc | 0.46 ± 0.15bc | 0.40 ± 0.02b | 0.63 ± 0.04c |
| beta-elemene | 93 | 0.10 ± 0.02a | 0.26 ± 0.0b | 0.25 ± 0.04b | 0.20 ± 0.01b | 0.26 ± 0.02b |
| Calarene | 161 | 0.30 ± 0.01a | 0.80 ± 0.04bc | 0.74 ± 0.23bc | 0.65 ± 0.04b | 0.97 ± 0.11c |
| Cadinene | 161 | 0.10 ± 0.03a | 0.32 ± 0.04bc | 0.27 ± 0.07bc | 0.24 ± 0.02b | 0.35 ± 0.04c |
Different letters within each row indicate a statistically significant difference among the samples (p < 0.05). * Asterisked compounds were acquired commercially and used as standards for identification purposes.